Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | XXII 0.1977 -8.34% | SHFS 0.1324 -61.39% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | YFOR 0.2236 -1.58% | RBNE 0.19 -2.56% | TQQQ 66.29 -0.20% | VZ 44.66 -1.19% | TSLL 9.76 -1.21% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | SQQQ 39.68 0.20% | AIOK 12.02 182.82% | ONDS 6.2 2.99% | AAPL 347.725 -0.14% | LABT 0.31 -36.67% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | GRAB 2.79 -2.11% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | IREN 24.905 -2.37% | QID 14.55 0.14% | RKT 11.73 -0.09% | WULF 11.32 0.00% | BE 193.3 -11.24%
HLHaleon plc logo

Haleon plc (HLN)

New York Stock Exchange · Currency in USD
$10.27 ▼ -0.10 (-0.96%)
At close: Oct 23, 4:00 PM ET. Market closed.

Summary

Previous Close
$10.37
Open
$10.30
Day's Range
$10.22 – $10.34
52 Week Range
$8.65 – $11.28
Volume
15,066,421
Avg. Volume
13,470,903
Market Cap
$45.16B
Beta (5Y Monthly)
0.25
PE Ratio (TTM)
21.01
EPS (TTM)
$0.36
Earnings Date
Mar 4, 2027
Forward Dividend & Yield
$0.13 (1.26%)
Ex-Dividend Date
Aug 14, 2026
1y Target Est
$10.20

Profile: Haleon plc

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Full-time employees
24,535
CEO
Brian James McNamara
Website
haleon.com

Haleon plc is a significant global entity in the consumer healthcare sector, engaging in the entire process from scientific research and development to the production and worldwide distribution of various wellness goods. The company's reach extends across North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific region. Its diverse product portfolio encompasses therapeutic solutions for oral care, pain management, respiratory well-being, and digestive health, alongside a comprehensive range of vitamins, minerals, and other dietary supplements.

Earnings

Next report: Thu, Mar 4, 2027
EPS estimate $0.28 · Revenue est. $7.68B
DateEst.Actual
Jul 30, 2026$0.27$0.28Beat
Feb 25, 2026$0.25$0.26Beat
Jul 31, 2025$0.24$0.24Miss
Feb 27, 2025$0.22$0.23Beat
Oct 31, 2024$0.11$0.23Beat
May 1, 2024$0.11$0.12Beat

Analyst view

Consensus price target
$10.20 ▼ -0.7%
Range $10.20 – $10.20
Rating: Buy
Buy 75% · Hold 25% · Sell 0%

Get free alerts on HLN and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.